Roadmap Consensus on Carotid Artery Plaque Imaging and Impact on Therapy Strategies and Guidelines: An International, Multispecialty, Expert Review and Position Statement

References

1. 1.↵
   GBD 2016 Stroke Collaborators. Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2019;18:43–58 doi:10.1016/S1474-4422(19)30034-1 pmid:30871944

   CrossRefPubMed
2. 2.↵
   1. Cheng SF,
   2. Brown MM,
   3. Simister RJ, et al

   . Contemporary prevalence of carotid stenosis in patients presenting with ischaemic stroke. Br J Surg 2019;106:872–78 doi:10.1002/bjs.11136 pmid:30938840

   CrossRefPubMed
3. 3.↵
   1. Mohr JP,
   2. Caplan LR,
   3. Melski JW, et al

   . The Harvard Cooperative Stroke Registry: a prospective registry. Neurology 1978;28:754–62 doi:10.1212/wnl.28.8.754 pmid:567291

   CrossRefPubMed
4. 4.↵
   1. Kumamaru H,
   2. Jalbert JJ,
   3. Nguyen LL, et al

   . Surgeon case volume and 30-day mortality after carotid endarterectomy among contemporary Medicare beneficiaries: before and after national coverage determination for carotid artery stenting. Stroke 2015;46:1288–94 doi:10.1161/STROKEAHA.114.006276 pmid:25791713

   Abstract/FREE Full Text
5. 5.↵
   1. Abbott AL,
   2. Adelman MA,
   3. Alexandrov AV, et al

   . Why calls for more routine carotid stenting are currently inappropriate: an international, multispecialty, expert review and position statement. Stroke 2013;44:1186–90 doi:10.1161/STROKEAHA.111.000261 pmid:23512977

   FREE Full Text
6. 6.↵
   1. Munster AB,
   2. Franchini AJ,
   3. Qureshi MI, et al

   . Temporal trends in safety of carotid endarterectomy in asymptomatic patients. Neurology 2015;85:365–72 doi:10.1212/WNL.0000000000001781 pmid:26115734

   Abstract/FREE Full Text
7. 7.↵
   1. Ridker PM,
   2. Everett BM,
   3. Thuren T, et al

   . CANTOS Trial Group. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med 2017;377:1119–31 doi:10.1056/NEJMoa1707914 pmid:28845751

   CrossRefPubMed
8. 8.↵
   1. Abbott AL

   . Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis: results of a systematic review and analysis. Stroke 2009;40:e573–83 doi:10.1161/STROKEAHA.109.556068 pmid:19696421

   Abstract/FREE Full Text
9. 9.↵
   1. Naylor AR,
   2. Gaines PA,
   3. Rothwell PM

   . Who benefits most from intervention for asymptomatic carotid stenosis: patients or professionals? Eur J Vasc Endovasc Surg 2009;37:625–32 doi:10.1016/j.ejvs.2009.01.026 pmid:19345591

   CrossRefPubMed
10. 10.↵
    1. Naylor AR

    . Time to rethink management strategies in asymptomatic carotid artery disease. Nat Rev Cardiol 2011;9:116–24 doi:10.1038/nrcardio.2011.151 pmid:21989048

    CrossRefPubMed
11. 11.↵
    1. Ibrahimi P,
    2. Jashari F,
    3. Bajraktari G, et al

    . Ultrasound assessment of carotid plaque echogenicity response to statin therapy: a systematic review and meta-analysis. Int J Mol Sci 2015;16:10734–47 doi:10.3390/ijms160510734 pmid:25984600

    CrossRefPubMed
12. 12.↵
    1. Perisic L,
    2. Aldi S,
    3. Sun Y, et al

    . Gene expression signatures, pathways and networks in carotid atherosclerosis. J Intern Med 2016;279:293–308 doi:10.1111/joim.12448 pmid:26620734

    CrossRefPubMed
13. 13.↵
    1. Mujaj B,
    2. Bos D,
    3. Selwaness M, et al

    . Statin use is associated with carotid plaque composition: the Rotterdam Study. Int J Cardiol 2018;260:213–18 doi:10.1016/j.ijcard.2018.02.111 pmid:29519676

    CrossRefPubMed
14. 14.↵
    1. Karlöf E,
    2. Seime T,
    3. Dias N, et al

    . Correlation of computed tomography with carotid plaque transcriptomes associates calcification with lesion-stabilization. Atherosclerosis 2019;288:175–85 doi:10.1016/j.atherosclerosis.2019.05.005 pmid:31109707

    CrossRefPubMed
15. 15.↵
    1. Kapadia M,
    2. Mehri-Basha M,
    3. Madhavan R, et al

    . High rate of inappropriate carotid endarterectomy in an urban medical center. J Stroke Cerebrovasc Dis 2009;18:277–80 doi:10.1016/j.jstrokecerebrovasdis.2008.11.010 pmid:19560681

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Barnett HJ,
    2. Taylor DW,
    3. Eliasziw M, et al

    . Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. N Engl J Med 1998;339:1415–25 doi:10.1056/NEJM199811123392002 pmid:9811916

    CrossRefPubMedWeb of Science
17. 17.↵
    Endarterectomy for asymptomatic carotid artery stenosis: Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA 1995;273:1421–28 pmid:7723155

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Abbott AL,
    2. Paraskevas KI,
    3. Kakkos SK, et al

    . Systematic review of guidelines for the management of asymptomatic and symptomatic carotid stenosis. Stroke 2015;46:3288–301 doi:10.1161/STROKEAHA.115.003390 pmid:26451020

    Abstract/FREE Full Text
19. 19.↵
    1. Ricotta JJ,
    2. Aburahma A,
    3. Ascher E, et al

    . Updated Society for Vascular Surgery guidelines for management of extracranial carotid disease. J Vasc Surg 2011;54:e1–31 doi:10.1016/j.jvs.2011.07.031 pmid:21889701

    CrossRefPubMed
20. 20.↵
    1. Ricotta JJ,
    2. AbuRahma A,
    3. Ascher E, et al

    . Updated Society for Vascular Surgery guidelines for management of extracranial carotid disease: executive summary. J Vasc Surg 2011;54:832–36 doi:10.1016/j.jvs.2011.07.004 pmid:21889705

    CrossRefPubMed
21. 21.↵
    1. Lanza G,
    2. Ricci S,
    3. Setacci C, et al

    . An update on Italian Stroke Organization guidelines on carotid endarterectomy and stenting. Int J Stroke 2014;9 Suppl A100:14–19 doi:10.1111/ijs.12226 pmid:24373487

    CrossRefPubMed
22. 22.↵
    1. Naylor AR,
    2. Ricco JB,
    3. de Borst GJ, et al

    . Editor’s Choice: Management of Atherosclerotic Carotid and Vertebral Artery Disease—2017 Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg 2018;55:3–81 doi:10.1016/j.ejvs.2017.06.021 pmid:28851594

    CrossRefPubMed
23. 23.↵
    1. Aboyans V,
    2. Ricco JB,
    3. Bartelink ML, et al

    . ESC Scientific Document Group. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries endorsed by: the European Stroke Organization (ESO), The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC), and of the European Society for Vascular Surgery (ESVS). Eur Heart J 2018;39:763–816 doi:10.1093/eurheartj/ehx095 pmid:28886620

    CrossRefPubMed
24. 24.↵
    1. Kopczak A,
    2. Schindler A,
    3. Bayer-Karpinska A, et al

    . Complicated carotid artery plaques as a cause of cryptogenic stroke. J Am Coll Cardiol 2020;76:2212–22 doi:10.1016/j.jacc.2020.09.532 pmid:33153580

    CrossRefPubMed
25. 25.↵
    1. Estol CJ

    . Dr C: Miller Fisher and the history of carotid artery disease. Stroke 1996;27:559–66 doi:10.1161/01.str.27.3.559 pmid:8610329

    Abstract/FREE Full Text
26. 26.↵
    1. Ogata J,
    2. Masuda J,
    3. Yutani C, et al

    . Rupture of atheromatous plaque as a cause of thrombotic occlusion of stenotic internal carotid artery. Stroke 1990;21:1740–45 doi:10.1161/01.str.21.12.1740 pmid:2264082

    Abstract/FREE Full Text
27. 27.↵
    1. Carr S,
    2. Farb A,
    3. Pearce WH, et al

    . Atherosclerotic plaque rupture in symptomatic carotid artery stenosis. J Vasc Surg 1996;23:755–65; discussion 765–66 doi:10.1016/S0741-5214(96)70237-9 pmid:8667496

    CrossRefPubMedWeb of Science
28. 28.↵
    1. Avril G,
    2. Batt M,
    3. Guidoin R, et al

    . Carotid endarterectomy plaques: correlations of clinical and anatomic findings. Ann Vasc Surg 1991;5:50–54 doi:10.1007/BF02021778 pmid:1997076

    CrossRefPubMed
29. 29.↵
    1. Lusby RJ,
    2. Ferrell LD,
    3. Ehrenfeld WK, et al

    . Carotid plaque hemorrhage. Arch Surg 1982;117:1479–88 doi:10.1001/archsurg.1982.01380350069010 pmid:6182861

    CrossRefPubMedWeb of Science
30. 30.↵
    1. Imparato AM,
    2. Riles TS,
    3. Mintzer R, et al

    . The importance of hemorrhage in the relationship between gross morphologic characteristics and cerebral symptoms in 376 carotid artery plaques. Ann Surg 1983;197:195–203 doi:10.1097/00000658-198302000-00012 pmid:6824372

    CrossRefPubMedWeb of Science
31. 31.↵
    1. Kwee RM

    . Systematic review on the association between calcification in carotid plaques and clinical ischemic symptoms. J Vasc Surg 2010;51:1015–25 doi:10.1016/j.jvs.2009.08.072 pmid:20045615

    CrossRefPubMed
32. 32.↵
    1. Finn AV,
    2. Nakano M,
    3. Narula J, et al

    . Concept of vulnerable/unstable plaque. Arterioscler Thromb Vasc Biol 2010;30:1282–92 doi:10.1161/ATVBAHA.108.179739 pmid:20554950

    Abstract/FREE Full Text
33. 33.↵
    1. Gunning AJ,
    2. Pickering GW,
    3. Robb-Smith AH, et al

    . Mural thrombosis of the internal carotid artery and subsequent embolism. Q J Med 1964;33:155–95 pmid:14116853

    PubMed
34. 34.↵
    1. Eikelboom BC,
    2. Riles TR,
    3. Mintzer R, et al

    . Inaccuracy of angiography in the diagnosis of carotid ulceration. Stroke 1983;14:882–85 doi:10.1161/01.str.14.6.882 pmid:6658990

    Abstract/FREE Full Text
35. 35.↵
    1. Ammar AD,
    2. Wilson RL,
    3. Travers H, et al

    . Intraplaque hemorrhage: its significance in cerebrovascular disease. Am J Surg 1984;148:840–43 doi:10.1016/0002-9610(84)90450-1 pmid:6507760

    CrossRefPubMedWeb of Science
36. 36.↵
    1. Ricotta JJ,
    2. Schenk EA,
    3. Ekholm SE, et al

    . Angiographic and pathologic correlates in carotid artery disease. Surgery 1986;99:284–92

    PubMedWeb of Science
37. 37.↵
    1. Lennihan L,
    2. Kupsky WJ,
    3. Mohr JP, et al

    . Lack of association between carotid plaque hematoma and ischemic cerebral symptoms. Stroke 1987;18:879–81 doi:10.1161/01.str.18.5.879 pmid:3629646

    Abstract/FREE Full Text
38. 38.↵
    1. Svindland A,
    2. Torvik A

    . Atherosclerotic carotid disease in asymptomatic individuals: An histological study of 53 cases. Acta Neurol Scand 1988;78:506–17 doi:10.1111/j.1600-0404.1988.tb03694.x pmid:3223238

    CrossRefPubMedWeb of Science
39. 39.↵
    1. Bassiouny HS,
    2. Davis H,
    3. Massawa N, et al

    . Critical carotid stenoses: morphologic and chemical similarity between symptomatic and asymptomatic plaques. J Vasc Surg 1989;9:202–12 pmid:2537432

    CrossRefPubMedWeb of Science
40. 40.↵
    1. Bassiouny HS,
    2. Sakaguchi Y,
    3. Mikucki SA, et al

    . Juxtalumenal location of plaque necrosis and neoformation in symptomatic carotid stenosis. J Vasc Surg 1997;26:585–94 doi:10.1016/S0741-5214(97)70056-9 pmid:9357458

    CrossRefPubMedWeb of Science
41. 41.↵
    1. Fisher CM,
    2. Ojemann RG

    . A clinico-pathologic study of carotid endarterectomy plaques. Rev Neurol (Paris) 1986;142:573–89 pmid:3797929

    PubMed
42. 42.↵
    1. Loree HM,
    2. Kamm RD,
    3. Stringfellow RG, et al

    . Effects of fibrous cap thickness on peak circumferential stress in model atherosclerotic vessels. Circ Res 1992;71:850–58 doi:10.1161/01.res.71.4.850 pmid:1516158

    Abstract/FREE Full Text
43. 43.↵
    1. Stary HC,
    2. Chandler AB,
    3. Dinsmore RE, et al

    . A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol 1995;15:1512–31 doi:10.1161/01.atv.15.9.1512 pmid:7670967

    Abstract/FREE Full Text
44. 44.↵
    1. Stary HC

    . Natural history and histological classification of atherosclerotic lesions: an update. [Editorial]. Arterioscler Thromb Vasc Biol 2000;20:1177–78 doi:10.1161/01.ATV.20.5.1177 pmid:10807728

    FREE Full Text
45. 45.↵
    1. Cai JM,
    2. Hatsukami TS,
    3. Ferguson MS, et al

    . Classification of human carotid atherosclerotic lesions with in vivo multicontrast magnetic resonance imaging. Circulation 2002;106:1368–73

    Abstract/FREE Full Text
46. 46.↵
    1. Hetterich H,
    2. Webber N,
    3. Willner M, et al

    . AHA classification of coronary and carotid atherosclerotic plaques by grating-based phase-contrast computed tomography. Eur Radiol 2016;26:3223–33 doi:10.1007/s00330-015-4143-z pmid:26679184

    CrossRefPubMed
47. 47.↵
    1. Virmani R,
    2. Kolodgie FD,
    3. Burke AP, et al

    . Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000;20:1262–75 doi:10.1161/01.atv.20.5.1262 pmid:10807742

    FREE Full Text
48. 48.↵
    1. Virmani R,
    2. Burke AP,
    3. Farb A, et al

    . Pathology of the vulnerable plaque. J Am Coll Cardiol 2006;47:(8 Suppl):C13–18 doi:10.1016/j.jacc.2005.10.065 pmid:16631505

    FREE Full Text
49. 49.↵
    1. Qureshi AI,
    2. Janardhan V,
    3. Bennett SE, et al

    . Who should be screened for asymptomatic carotid artery stenosis? Experience from the Western New York Stroke Screening Program. J Neuroimaging 2001;11:105–11 doi:10.1111/j.1552-6569.2001.tb00019.x pmid:11296578

    CrossRefPubMedWeb of Science
50. 50.↵
    1. Yaghi S,
    2. Elkind MV

    . Cryptogenic stroke: a diagnostic challenge. Neurol Clin Pract 2014;4:386–93 doi:10.1212/CPJ.0000000000000086 pmid:25317376

    Abstract/FREE Full Text
51. 51.↵
    1. Yaghi S,
    2. Bernstein RA,
    3. Passman R, et al

    . Cryptogenic stroke: research and practice. Circ Res 2017;120:527–40 doi:10.1161/CIRCRESAHA.116.308447 pmid:28154102

    Abstract/FREE Full Text
52. 52.↵
    1. Ferguson GG,
    2. Eliasziw M,
    3. Barr HW, et al

    . Surgical results in 1415 patients. Stroke 1999;30:1751–58 doi:10.1161/01.str.30.9.1751 pmid:10471419

    Abstract/FREE Full Text
53. 53.↵
    1. Saam T,
    2. Hetterich H,
    3. Hoffmann V, et al

    . Meta-analysis and systematic review of the predictive value of carotid plaque hemorrhage on cerebrovascular events by magnetic resonance imaging. J Am Coll Cardiol 2013;62:1081–91 doi:10.1016/j.jacc.2013.06.015 pmid:23850912

    FREE Full Text
54. 54.↵
    1. Gupta A,
    2. Baradaran H,
    3. Schweitzer AD, et al

    . Carotid plaque MRI and stroke risk: a systematic review and meta-analysis. Stroke 2013;44:3071–77 doi:10.1161/STROKEAHA.113.002551 pmid:23988640

    Abstract/FREE Full Text
55. 55.↵
    1. Schindler A,
    2. Schinner R,
    3. Altaf N, et al

    . Prediction of stroke risk by detection of hemorrhage in carotid plaques: meta-analysis of individual patient data. JACC Cardiovasc Imaging 2020;13(2 Pt 1):395–406 doi:10.1016/j.jcmg.2019.03.028 pmid:31202755

    CrossRefPubMed
56. 56.↵
    1. Nandalur KR,
    2. Hardie AD,
    3. Raghavan P, et al

    . Composition of the stable carotid plaque: Insights from a multidetector computed tomography study of plaque volume. Stroke 2007;38:935–40 doi:10.1161/01.STR.0000257995.74834.92 pmid:17272781

    Abstract/FREE Full Text
57. 57.↵
    1. Saba L,
    2. Saam T,
    3. Jäger HR, et al

    . Imaging biomarkers of vulnerable carotid plaques for stroke risk prediction and their potential clinical implications. Lancet Neurol 2019;4422:1–14 doi:10.1016/S1474-4422(19)30035-3 pmid:30954372

    CrossRefPubMed
58. 58.↵
    1. Simpson RJ,
    2. Akwei S,
    3. Hosseini AA, et al

    . MR imaging-detected carotid plaque hemorrhage is stable for 2 years and a marker for stenosis progression. Am J Neuroradiol 2015;36:1171–75 doi:10.3174/ajnr.A4267 pmid:25742988

    Abstract/FREE Full Text
59. 59.↵
    1. Underhill HR,
    2. Yuan C

    . Carotid MRI: a tool for monitoring individual response to cardiovascular therapy? Expert Rev Cardiovasc Ther 2011;9:63–80 doi:10.1586/erc.10.172 pmid:21166529

    CrossRefPubMed
60. 60.↵
    1. Takaya N,
    2. Yuan C,
    3. Chu B, et al

    . Presence of intraplaque hemorrhage stimulates progression of carotid atherosclerotic plaques: a high-resolution magnetic resonance imaging study. Circulation 2005;111:2768–75 doi:10.1161/CIRCULATIONAHA.104.504167 pmid:15911695

    Abstract/FREE Full Text
61. 61.↵
    1. Underhill HR,
    2. Yuan C,
    3. Yarnykh VL, et al

    . Arterial remodeling in [corrected] subclinical carotid artery disease. JACC Cardiovasc Imaging 2009;2:1381–89 doi:10.1016/j.jcmg.2009.08.007 pmid:20083072

    Abstract/FREE Full Text
62. 62.↵
    1. Underhill HR,
    2. Yuan C,
    3. Yarnykh VL, et al

    . Predictors of surface disruption with MR imaging in asymptomatic carotid artery stenosis. AJNR Am J Neuroradiol 2010;31:487–93 doi:10.3174/ajnr.A1842 pmid:19833801

    Abstract/FREE Full Text
63. 63.↵
    1. Sun J,
    2. Underhill HR,
    3. Hippe DS, et al

    . Sustained acceleration in carotid atherosclerotic plaque progression with intraplaque hemorrhage: a long-term time course study. JACC Cardiovasc Imaging 2012;5:798–804 doi:10.1016/j.jcmg.2012.03.014 pmid:22897993

    Abstract/FREE Full Text
64. 64.↵
    1. Pletsch-Borba L,
    2. Selwaness M,
    3. van der Lugt A, et al

    . Change in carotid plaque components: a 4-year follow-up study with serial MR imaging. JACC Cardiovasc Imaging 2018;11:184–92 doi:10.1016/j.jcmg.2016.12.026 pmid:28412421

    Abstract/FREE Full Text
65. 65.↵
    1. Burke AP,
    2. Kolodgie FD,
    3. Farb A, et al

    . Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has a role in plaque progression. Circulation 2001;103:934–40 doi:10.1161/01.cir.103.7.934 pmid:11181466

    Abstract/FREE Full Text
66. 66.↵
    1. Corti R,
    2. Fayad ZA,
    3. Fuster V, et al

    . Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imaging. Circulation 2001;104:249–52 doi:10.1161/01.CIR.104.3.249 pmid:11457739

    Abstract/FREE Full Text
67. 67.↵
    1. Zhao X-Q,
    2. Dong L,
    3. Hatsukami T, et al

    . MR imaging of carotid plaque composition during lipid-lowering therapy a prospective assessment of effect and time course. JACC Cardiovasc Imaging 2011;4:977–86 doi:10.1016/j.jcmg.2011.06.013 pmid:21920335

    Abstract/FREE Full Text
68. 68.↵
    1. Underhill HR,
    2. Yuan C,
    3. Zhao XQ, et al

    . Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients: a high-resolution magnetic resonance imaging trial. Am Heart J 2008;155:584.e1–8 doi:10.1016/j.ahj.2007.11.018 pmid:18294500

    CrossRefPubMed
69. 69.↵
    1. DeMarco JK,
    2. Spence JD

    . Plaque assessment in the management of patients with asymptomatic carotid stenosis. Neuroimaging Clin N Am 2016;26:111–27 doi:10.1016/j.nic.2015.09.009 pmid:26610664

    CrossRefPubMed
70. 70.↵
    1. Spence JD,
    2. Hackam DG

    . Treating arteries instead of risk factors: a paradigm change in management of atherosclerosis. Stroke 2010;41:1193–99 doi:10.1161/STROKEAHA.110.577973 pmid:20413738

    Abstract/FREE Full Text
71. 71.↵
    1. Spence JD,
    2. Coates V,
    3. Li H, et al

    . Effects of intensive medical therapy on microemboli and cardiovascular risk in asymptomatic carotid stenosis. Arch Neurol 2010;67:180–86 doi:10.1001/archneurol.2009.289 pmid:20008646

    CrossRefPubMedWeb of Science
72. 72.↵
    GBD 2016 Neurology Collaborators. Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2019;18:459–80 doi:10.1016/S1474-4422(18)30499-X pmid:30879893

    CrossRefPubMed
73. 73.↵
    1. Iso H,
    2. Jacobs DR,
    3. Wentworth D, et al

    . Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. N Engl J Med 1989;320:904–10 doi:10.1056/NEJM198904063201405 pmid:2619783

    CrossRefPubMedWeb of Science
74. 74.↵
    1. Chan DK,
    2. O’Rourke F,
    3. Shen Q, et al

    . Meta-analysis of the cardiovascular benefits of intensive lipid lowering with statins. Acta Neurol Scand 2011;124:188–95 doi:10.1111/j.1600-0404.2010.01450.x pmid:20979581

    CrossRefPubMed
75. 75.↵
    1. Cannon CP,
    2. Steinberg BA,
    3. Murphy SA, et al

    . Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy. J Am Coll Cardiol 2006;48:438–45 doi:10.1016/j.jacc.2006.04.070 pmid:16875966

    FREE Full Text
76. 76.↵
    1. Everett BM,
    2. Glynn RJ,
    3. MacFadyen JG, et al

    . Rosuvastatin in the prevention of stroke among men and women with elevated levels of C-reactive protein: Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER). Circulation 2010;121:143–50 doi:10.1161/CIRCULATIONAHA.109.874834 pmid:20026779

    Abstract/FREE Full Text
77. 77.↵
    1. Cannon CP,
    2. Blazing MA,
    3. Giugliano RP, et al

    . Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med 2015;372:2387–97 doi:10.1056/NEJMoa1410489 pmid:26039521

    CrossRefPubMed
78. 78.↵
    1. Sabatine MS,
    2. Giugliano RP,
    3. Keech AC, et al

    . Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med 2017;376:1713–22 doi:10.1056/NEJMoa1615664 pmid:28304224

    CrossRefPubMed
79. 79.↵
    1. Landmesser U,
    2. Chapman MJ,
    3. Stock JK, et al

    . 2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia. Eur Heart J 2018;39:1131–43 doi:10.1093/eurheartj/ehx549 pmid:29045644

    CrossRefPubMed
80. 80.↵
    1. O'Brien KD,
    2. Hippe DS,
    3. Chen H, et al

    . Longer duration of statin therapy is associated with decreased carotid plaque vascularity by magnetic resonance imaging. Atherosclerosis 2016;245:74–81 doi:10.1016/j.atherosclerosis.2015.11.032

    CrossRef
81. 81.↵
    1. Du R,
    2. Cai J,
    3. Cui B, et al

    . Rapid improvement in carotid adventitial angiogenesis and plaque neovascularization after rosuvastatin therapy in statin treatment–naïve subjects. J Clin Lipidol 2019;13:847–53 doi:10.1016/j.jacl.2019.07.008 pmid:31783975

    CrossRefPubMed
82. 82.↵
    The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke—International Stroke Trial Collaborative Group. Lancet (London, England) 1997;349:1569–81 doi:10.1016/S0140-6736(97)04011-7 pmid:9174558

    CrossRefPubMedWeb of Science
83. 83.↵
    1. Russell DA,
    2. Wijeyaratne SM,
    3. Gough MJ

    . Relationship of carotid plaque echomorphology to presenting symptom. Eur J Vasc Endovasc Surg 2010;39:134–38 doi:10.1016/j.ejvs.2009.11.003 pmid:19939712

    CrossRefPubMed
84. 84.↵
    1. Halkes PH,
    2. van Gijn J,
    3. Kappelle LJ, et al

    . ESPRIT Study Group. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet 2006;367:1665–73 doi:10.1016/S0140-6736(06)68734-5 pmid:16714187

    CrossRefPubMedWeb of Science
85. 85.↵
    1. Diener HC,
    2. Sacco RL,
    3. Yusuf S, et al

    . Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) study group. Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study. Lancet Neurol 2008;7:875–84 doi:10.1016/S1474-4422(08)70198-4 pmid:18757238

    CrossRefPubMedWeb of Science
86. 86.↵
    1. Madani A,
    2. Beletsky V,
    3. Tamayo A, et al

    . High-risk asymptomatic carotid stenosis: ulceration on 3D ultrasound vs TCD microemboli. Neurology 2011;77:744–50 doi:10.1212/WNL.0b013e31822b0090 pmid:21849642

    Abstract/FREE Full Text
87. 87.↵
    1. Kakkos SK,
    2. Griffin MB,
    3. Nicolaides AN, et al

    . The size of juxtaluminal hypoechoic area in ultrasound images of asymptomatic carotid plaques predicts the occurrence of stroke. J Vasc Surg 2013;57:609–18.e1; discussion 617–18 doi:10.1016/j.jvs.2012.09.045 pmid:23337294

    CrossRefPubMed
88. 88.↵
    1. Rothwell PM,
    2. Algra A,
    3. Chen Z, et al

    . Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials. Lancet 2016;388:365–75 doi:10.1016/S0140-6736(16)30468-8 pmid:27209146

    CrossRefPubMed
89. 89.↵
    1. Bhatt DL,
    2. Fox KA,
    3. Hacke W, et al

    . CHARISMA Investigators. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006;354:1706–17 doi:10.1056/NEJMoa060989 pmid:16531616

    CrossRefPubMedWeb of Science
90. 90.↵
    1. Hong S,
    2. Nam M,
    3. Little BB, et al

    . Randomized control trial comparing the effect of cilostazol and aspirin on changes in carotid intima-medial thickness. Heart Vessels 2019;34:1758–68 doi:10.1007/s00380-019-01421-1 pmid:31056733

    CrossRefPubMed
91. 91.↵
    1. Eikelboom JW,
    2. Connolly SJ,
    3. Bosch J, et al

    . Rivaroxaban with or without aspirin in stable cardiovascular disease. N Engl J Med 2017;377:1319–30 doi:10.1056/NEJMoa1709118 pmid:28844192

    CrossRefPubMed
92. 92.↵
    1. Ameriso SF,
    2. Amarenco P,
    3. Pearce LA, et al

    . Intracranial and systemic atherosclerosis in the NAVIGATE ESUS trial: recurrent stroke risk and response to antithrombotic therapy. J Stroke Cerebrovasc Dis 2020;29:104936 doi:10.1016/j.jstrokecerebrovasdis.2020 pmid:32689594

    CrossRefPubMed
93. 93.↵
    1. Seneviratne AN,
    2. Monaco C

    . Role of inflammatory cells and toll-like receptors in atherosclerosis. Curr Vasc Pharmacol 2015;13:146–60 doi:10.2174/15701611113116660160 pmid:24188491

    CrossRefPubMed
94. 94.↵
    1. Bäck M,
    2. Hansson GK

    . Anti-inflammatory therapies for atherosclerosis. Nat Rev Cardiol 2015;12:199–211 doi:10.1038/nrcardio.2015.5 pmid:25666404

    CrossRefPubMed
95. 95.↵
    1. Tsivgoulis G,
    2. Katsanos AH,
    3. Giannopoulos G, et al

    . The role of colchicine in the prevention of cerebrovascular ischemia. Curr Pharm Des 2018;24:668–74 doi:10.2174/1381612824666180116100310 pmid:29336246

    CrossRefPubMed
96. 96.↵
    1. Nidorf SM,
    2. Eikelboom JW,
    3. Budgeon CA, et al

    . Low-dose colchicine for secondary prevention of cardiovascular disease. J Am Coll Cardiol 2013;61:404–10 doi:10.1016/j.jacc.2012.10.027 pmid:23265346

    FREE Full Text
97. 97.↵
    1. Choi H,
    2. Uceda DE,
    3. Dey AK, et al

    . Treatment of psoriasis with biologic therapy is associated with improvement of coronary artery plaque lipid-rich necrotic core: results from a prospective, observational study. Circ Cardiovasc Imaging 2020;13:e011199 doi:10.1161/CIRCIMAGING.120.011199] pmid:32927971

    CrossRefPubMed
98. 98.↵
    1. Mahmoud R,
    2. Moody AR,
    3. Foster M, et al

    . Sharing de-identified medical images electronically for research: a survey of patients’ opinion regarding data management. Can Assoc Radiology J 2019;70:212–18 doi:10.1016/j.carj.2019.04.002 pmid:31376884

    CrossRefPubMed
99. 99.↵
    1. Paraskevas KI,
    2. Eckstein HH,
    3. Mikhailidis DP, et al

    . Rationale for screening selected patients for asymptomatic carotid artery stenosis. Curr Med Res Opin 2020;36:361–65 doi:10.1080/03007995.2020.1713075 pmid:31910676

    CrossRefPubMed